Integrating artificial intelligence and advanced analytics throughout operations offers pharma companies a pathway to offset impending drug patent expirations.
Alan Kalton
Advertisement
Articles by Alan Kalton
Top industry experts weigh in on what the new year holds for the pharma industry.
Exposing the truth behind AI myths highlighted by COVID.
Advertisement
Latest Updated Articles
Fortifying Defenses Pre-Patent CliffPublished: September 8th 2023 | Updated:
Top 5 Most Perpetuated AI Myths, DebunkedPublished: May 6th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Unsolicited Proposal to Acquire Metsera
2
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
3
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
4
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
5
